Navigating Japan’s Regulatory Challenges in CDx Development from A Pharmaceutical Company Perspective: Practical Solutions & Future Directions
- Current situation and challenges of Japan’s regulatory environment for CDx development compare to US/EU
- Case study of alternative diagnostic development based on these challenges
- Proposals for regulatory environment to advance future companion diagnostics development